Tech
The benefits and hidden costs of AI scribes
They may also be contributing to rising medical costs and could lead to higher insurance premiums, experts say.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
Retail Pharmacies
The government is forcing PBMs to be more transparent, but will reforms make a difference?
The Consolidated Appropriations Act, passed in February, included several significant reforms for PBMs.
Tech
Clinicians are using AI without guidance. What are the risks?
Unregulated AI use could leave healthcare institutions vulnerable to HIPAA violations, cyberattacks, experts say.
Pharma
Pharma companies home in on GLP-2s and GLP-3s in race to innovate on obesity treatments
Companies are looking at combining several hormone-like molecules to boost results.
Direct Care
What states are prioritizing with their first year of Rural Health Transformation funding
Though each state is allowed to create its own initiatives, there are some common themes nationwide.
Payers
A look at Medicare Advantage: Why it was created, and how it’s performed
The program has become a hot topic as government spending on it continues to rise.
Hospitals & Facilities
AstraZeneca’s head of sustainability on the pharma giant’s climate efforts
The company has set lofty goals, including decarbonizing its value chain by 2030.
Retail Pharmacies
Pharma execs look back on the first half of 2026
We spoke with leaders on how they’ve fared so far this year and what they’re focused on next.
Retail Pharmacies
Retail pharmacy leaders reflect on the first half of 2026
The sector’s landscape has changed rapidly in the last few years.
Direct Care
What PCOS’s name change means for healthcare
The new name opens research on the condition up to more NIH funding, an expert explains.